Thermo Fisher Scientific Inc.
TMO

$200.45 B
Marketcap
$524.05
Share price
Country
$7.36
Change (1 day)
$627.88
Year High
$493.30
Year Low

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

marketcap

P/E ratio for Thermo Fisher Scientific Inc. (TMO)

P/E ratio as of 2023: 34.18

According to Thermo Fisher Scientific Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 34.18. At the end of 2022 the company had a P/E ratio of 31.06.

P/E ratio history for Thermo Fisher Scientific Inc. from 1985 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 34.18
2022 31.06
2021 34.03
2020 28.93
2019 35.16
2018 30.62
2017 33.71
2016 27.55
2015 28.63
2014 26.34
2013 31.51
2012 19.70
2011 12.88
2010 21.56
2009 23.13
2008 14.33
2007 31.94
2006 52.57
2005 21.81
2004 13.61
2003 20.50
2002 10.87
2001 -5503.44
2000 -116.27
1999 -11.67
1998 13.00
1997 23.67
1996 24.08
1995 26.70
1994 18.38
1993 22.57
1992 18.47
1991 21.96
1990 15.33
1989 19.36
1988 15.07
1987 11.10
1986 17.79
1985 17.39